NCT01214889View on ClinicalTrials.gov

Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants.

PHASE3CompletedINTERVENTIONAL
Enrollment

370

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

November 30, 2011

Study Completion Date

December 31, 2011

Conditions
DiphtheriaTetanusPertussisPoliomyelitisHaemophilus Influenzae Type B
Interventions
BIOLOGICAL

PENTAXIM™: DTacP IPV//PRP~T combined vaccine

0.5 mL, intramuscular

BIOLOGICAL

TETRAXIM™: DTacP IPV combined vaccine and ActHIB™: PRP tetanus conjugate vaccine

0.5 mL of each vaccine; intramuscular

Trial Locations (14)

110744

Seoul

130702

Seoul

132703

Seoul

133792

Seoul

135710

Seoul

137701

Seoul

158710

Seoul

301723

Daejeon

400700

Incheon

403720

Incheon

405760

Incheon

411706

Gyeionggi Do

420767

Gyeonggi-do

420818

Gyeonggi-do

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY